Ronnie Ramlogan and Dimitri Gagliardi write about this ESRC-funded collaborative project between the Universities of Manchester and Liverpool which sets out to identify the critical factors affecting the adoption of pharmacogenetics/genomics as part of the NHS treatment regime for cardiovascular diseases.
![The organisation and diffusion of translational research: Can cardiovascular medicine learn from oncology? Case studies of pharmacogenomics in the NHS](https://blogs.manchester.ac.uk/mioir/wp-content/uploads/sites/409/2023/01/heart-dna-drugs-640x480.jpg)